Biocon Ltd Nine Monthly Results

Gross Sales

10,694.1

10,332

7,400.3

5,775.2

5,301

Excise Duty

0

0

0

0

0

Net Sales

10,694.1

10,332

7,400.3

5,775.2

5,301

Other Operating Income

150.6

506.6

0

0

0

Other Income

1,247.4

838.1

221

145.4

56.1

Total Income

12,092.1

11,676.7

7,621.3

5,920.6

5,357.1

Total Expenditure

8,756.6

8,561.3

6,301.2

4,620.9

4,100.6

PBIDT

3,335.5

3,115.4

1,320.1

1,299.7

1,256.5

Interest

685

747.4

170.2

57.1

23.8

PBDT

2,650.5

2,368

1,149.9

1,242.6

1,232.7

Depreciation

1,250.7

1,161.8

749.4

602

530.8

Minority Interest Before NP

0

0

0

0

0

Tax

383.1

178.4

280.9

152.9

152.1

Deferred Tax

46.7

-47.1

-108.9

0

0

Reported Profit After Tax

970

1,074.9

228.5

487.7

549.8

Minority Interest After NP

301.2

187.9

79

77.9

62.5

Net Profit after Minority Interest

668.8

887

149.5

409.8

487.3

Extra-ordinary Items

52.73

-2.39

-86.12

-53.37

0

Adjusted Profit After Extra-ordinary item

616.07

889.39

235.62

463.17

487.3

EPS (Unit Curr.)

5.59

7.42

1.25

3.44

4.11

Book Value (Unit Curr.)

0

0

0

0

0

Dividend (%)

0

0

0

0

0

Equity

600.3

600.3

600.3

600.3

600

Public Shareholding (Number)

0

0

0

0

0

Public Shareholding (%)

0

0

0

0

0

Pledged/Encumbered - No. of Shares

0

0

0

0

0

Pledged/Encumbered - % in Total Promoters Holding

0

0

0

0

0

Pledged/Encumbered - % in Total Equity

0

0

0

0

0

Non Encumbered - No. of Shares

0

0

0

0

0

Non Encumbered - % in Total Promoters Holding

0

0

0

0

0

Non Encumbered - % in Total Equity

0

0

0

0

0

PBIDTM(%)

31.19

30.15

17.83

22.5

23.7

PBDTM(%)

24.78

22.91

15.53

21.51

23.25

PATM(%)

9.07

10.4

3.08

8.44

10.37